| 0.2693 0.028 (11.42%) | 03-02 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.34  |
1-year : | 0.4 |
| Resists | First : | 0.29 |
Second : | 0.34 |
| Pivot price | 0.23 |
|||
| Supports | First : | 0.23 |
Second : | 0.19 |
| MAs | MA(5) : | 0.24 |
MA(20) : | 0.23 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 74.3 |
D(3) : | 69.2 |
| RSI | RSI(14): 40.4 |
|||
| 52-week | High : | 6.42 | Low : | 0.19 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ POM ] has closed above the upper band by 12.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 0.27 - 0.27 | 0.27 - 0.27 |
| Low: | 0.23 - 0.23 | 0.23 - 0.23 |
| Close: | 0.27 - 0.27 | 0.27 - 0.27 |
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Mon, 02 Mar 2026
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - PR Newswire
Mon, 02 Mar 2026
Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Mon, 02 Mar 2026
Portnoy Law Firm Announces Class Action on Behalf of PomDoctor Ltd. Investors - GlobeNewswire
Sat, 28 Feb 2026
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors with Losses in Excess ... - Bluefield Daily Telegraph
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 107 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.6 (%) |
| Shares Short | 226 (K) |
| Shares Short P.Month | 429 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -8.94 |
| Profit Margin | -40.6 % |
| Operating Margin | -6.6 % |
| Return on Assets (ttm) | -32.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 16.2 % |
| Gross Profit (p.s.) | 0.48 |
| Sales Per Share | 3.43 |
| EBITDA (p.s.) | -0.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -20 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -5.39 |
| PEG Ratio | 0 |
| Price to Book value | -0.04 |
| Price to Sales | 0.07 |
| Price to Cash Flow | -1.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|